The Excelsior Solutions Difference

PBM Consulting

Substantially reducing pharmacy benefit costs without sacrificing plan quality.

Specialty Drug Management

Managing one of the largest hidden costs of medical care.

Medicare & Medicaid

Navigating a complex marketplace.

ABOUT US

Your cutting-edge expert with the resources to manage your pharmacy program effectively, contain cost, and be accountable for the results. We are the next generation; we are the solution.

Insights & Publications

Q1 2023 Excelsior Newsletter

Drug Trends to Watch, Actions to Consider by Robert Kordella, RPh, MBASenior Vice President and Chief Clinical Officer DIABETES Rising prescription costs related to the

Q3 2022 Excelsior Newsletter

Excelsior’s Opinion on So-Called “Vision Enhancement Products” by Robert Kordella, RPh, MBA, Chief Clinical Officer Three products have come to market recently that are being

Q2 2022 Excelsior Newsletter

Humira Savings on the Horizon? by Robert Kordella, RPh, MBA, Chief Clinical Officer In 2021, Humira (adalimumab) amassed $21 billion in sales in the U.S.

Opioid Case Study

Opioid Case Study Annual Savings of  $192,000 Challenge Member filling pain

Humalog Lispro News

As you may recall, back in March of this year, Eli Lilly announced that they would begin to manufacture and sell an authorized generic version

Generic Advair Diskus Approved

The news that the FDA approved the first A-rated (meaning that pharmacists may freely substitute it without physician approval) generic form of Advair Diskus on

ICER Update 10.04.22

 Hello everyone, and welcome to this edition of Excelsior Solutions’ ICER Update. ICER released a Final Evidence Report assessing the comparative clinical effectiveness and value

ICER Update 01.27.22

Hello everyone, and welcome to this edition of Excelsior Solutions’ ICER Update. ICER has published its latest report on Unsupported Price Increases (UPI) of prescription

ICER Update 01.22.21

Hello, everyone, and welcome to this edition of Excelsior Solutions’ ICER Update. Here is this week’s ICER recap: ICER has published its latest report on